Critical Care Medicine

Skip Navigation LinksHome > July 2014 - Volume 42 - Issue 7 > A Comparison of Severe Hemodynamic Disturbances Between Dexm...
Critical Care Medicine:
doi: 10.1097/CCM.0000000000000328
Neurologic Critical Care

A Comparison of Severe Hemodynamic Disturbances Between Dexmedetomidine and Propofol for Sedation in Neurocritical Care Patients

Erdman, Michael J. PharmD, BCPS1; Doepker, Bruce A. PharmD, BCPS2,3; Gerlach, Anthony T. PharmD, BCPS, FCCM2,3; Phillips, Gary S. MAS4; Elijovich, Lucas MD5,6; Jones, G. Morgan PharmD, BCPS7,8

Supplemental Author Material
Collapse Box


Objective: Dexmedetomidine and propofol are commonly used sedatives in neurocritical care as they allow for frequent neurologic examinations. However, both agents are associated with significant hemodynamic side effects. The primary objective of this study is to compare the prevalence of severe hemodynamic effects in neurocritical care patients receiving dexmedetomidine and propofol.

Design: Multicenter, retrospective, propensity-matched cohort study.

Setting: Neurocritical care units at two academic medical centers with dedicated neurocritical care teams and board-certified neurointensivists.

Patients: Neurocritical care patients admitted between July 2009 and September 2012 were evaluated and then matched 1:1 based on propensity scoring of baseline characteristics.

Interventions: Continuous sedation with dexmedetomidine or propofol.

Measurements and Main Results: A total of 342 patients (105 dexmedetomidine and 237 propofol) were included in the analysis, with 190 matched (95 in each group) by propensity score. The primary outcome of this study was a composite of severe hypotension (mean arterial pressure < 60 mm Hg) and bradycardia (heart rate < 50 beats/min) during sedative infusion. No difference in the primary composite outcome in both the unmatched (30% vs 30%, p = 0.94) or matched cohorts (28% vs 34%, p = 0.35) could be found. When analyzed separately, no differences could be found in the prevalence of severe hypotension or bradycardia in either the unmatched or matched cohorts.

Conclusions: Severe hypotension and bradycardia occur at similar prevalence in neurocritical care patients who receive dexmedetomidine or propofol. Providers should similarly consider the likelihood of hypotension or bradycardia before starting either sedative.

© 2014 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.